Optimization of Salbutamol Sulfate Dissolution from Sustained Release Matrix Formulations Using an Artificial Neural Network
暂无分享,去创建一个
Faith Chaibva | Michael Burton | Roderick B. Walker | R. B. Walker | F. Chaibva | M. Burton | Michael Burton
[1] L. Maggi,et al. Matrices containing NaCMC and HPMC 2. Swelling and release mechanism study. , 2007, International journal of pharmaceutics.
[2] Kozo Takayama,et al. Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations , 1997 .
[3] Svetlana Ibrić,et al. The application of generalized regression neural network in the modeling and optimization of aspirin extended release tablets with Eudragit RS PO as matrix substance. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[4] Yixin Chen,et al. Application of artificial neural networks in the design of controlled release drug delivery systems. , 2003, Advanced drug delivery reviews.
[5] B. D. Rohera,et al. Comparative evaluation of rate of hydration and matrix erosion of HEC and HPC and study of drug release from their matrices. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[6] P. Calverley,et al. Modern treatment of chronic obstructive pulmonary disease , 2001, European Respiratory Journal.
[7] J. W. Moore,et al. Mathematical comparison of dissolution profiles , 1996 .
[8] S. Rani,et al. Formulation and Evaluation of Controlled-Release Transdermal Patches of Theophylline–Salbutamol Sulfate , 2001, Drug development and industrial pharmacy.
[9] T Nagai,et al. Formula optimization of theophylline controlled-release tablet based on artificial neural networks. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[10] S. Baveja,et al. Zero-order release hydrophilic matrix tablets of β-adrenergic blockers , 1987 .
[11] G. Jayasagar,,et al. Formulation and Evaluation of Diclofenac Sodium Using Hydrophilic Matrices , 2001, Drug development and industrial pharmacy.
[12] M C Meyer,et al. The application of an artificial neural network and pharmacokinetic simulations in the design of controlled-release dosage forms. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[13] J. Schwartz,et al. Studies on Drug Release from a Carbomer Tablet Matrix , 1995 .
[14] Sean C. Sweetman,et al. Martindale: The Complete Drug Reference , 1999 .
[15] S. Baveja,et al. Sustained release tablet formulation of centperazine , 1986 .
[16] Peter York,et al. Optimisation of the predictive ability of artificial neural network (ANN) models: a comparison of three ANN programs and four classes of training algorithm. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[17] J Bourquin,et al. Comparison of artificial neural networks (ANN) with classical modelling techniques using different experimental designs and data from a galenical study on a solid dosage form. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[18] J. Sousa,et al. Role of Cellulose Ether Polymers on Ibuprofen Release from Matrix Tablets , 2005, Drug development and industrial pharmacy.
[19] Ping I. Lee. Diffusional release of a solute from a polymeric matrix — approximate analytical solutions , 1980 .
[20] Kozo Takayama,et al. Neural network based optimization of drug formulations. , 2003, Advanced drug delivery reviews.
[21] G. Khan,et al. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[22] Martin H. Abramson,et al. Complete Drug Reference , 1996 .
[23] Y Obata,et al. Simultaneous optimization based on artificial neural networks in ketoprofen hydrogel formula containing O-ethyl-3-butylcyclohexanol as percutaneous absorption enhancer. , 2001, Journal of pharmaceutical sciences.
[24] Rajiv Kumar,et al. Optimizing drug delivery systems using systematic "design of experiments." Part I: fundamental aspects. , 2005, Critical reviews in therapeutic drug carrier systems.
[25] Robert D. Johnson,et al. Application of Neural Computing in Pharmaceutical Product Development , 1991, Pharmaceutical Research.
[26] D. L. Munday,et al. Relationship between swelling, erosion and drug release in hydrophillic natural gum mini-matrix formulations. , 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[27] J. Siepmann,et al. Hydrophilic Matrices for Controlled Drug Delivery: An Improved Mathematical Model to Predict the Resulting Drug Release Kinetics (the “sequential Layer” Model) , 2004, Pharmaceutical Research.
[28] Christopher T. Rhodes,et al. Artificial Neural Networks: Implications for Pharmaceutical Sciences , 1995 .
[29] Franc Vrecer,et al. Optimization of diclofenac sodium dissolution from sustained release formulations using an artificial neural network , 1997 .
[30] M. Durrani,et al. Studies on Drug Release Kinetics from Carbomer Matrices , 1994 .
[31] R. Erb,et al. Introduction to Backpropagation Neural Network Computation , 1993, Pharmaceutical Research.
[32] J. Zhu,et al. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[33] R. Kinget,et al. Comparative study on xanthan gum and hydroxypropylmethyl cellulose as matrices for controlled-release drug delivery I. Compaction and in vitro drug release behaviour , 1996 .
[34] J. Parojčić,et al. Artificial neural networks in the modeling and optimization of aspirin extended release tablets with eudragit L 100 as matrix substance , 2008, AAPS PharmSciTech.
[35] T. Tsai,et al. Film-forming polymer-granulated excipients as the matrix materials for controlled release dosage forms. , 1998, Journal of controlled release : official journal of the Controlled Release Society.
[36] T Nagai,et al. Formula optimization based on artificial neural networks in transdermal drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[37] Nicholas A. Peppas,et al. Modelling of drug diffusion through swellable polymeric systems , 1980 .
[38] C. Ferrero,et al. Compaction properties, drug release kinetics and fronts movement studies from matrices combining mixtures of swellable and inert polymers: effect of HPMC of different viscosity grades. , 2008, International journal of pharmaceutics.